SPRAVATO®: Depression Treatment for Antidepressant Resistance
SPRAVATO®: Depression Treatment for Antidepressant Resistance
What is SPRAVATO®?
It is incredibly demoralizing to have a mood disorder that resists treatment again and again. It can feel like your last hope has failed you. But one of the great things about mental health care is that they are constantly working on new ways of treating people–and we’d like to introduce you to a wonderful alternative treatment.
SPRAVATO®, also known as esketamine, is a nasal spray that is self-administered by the patient while being monitored by a specially trained medical assistant at regular intervals. It is taken alongside other antidepressants and therapy, targeting different neural receptors in the brain. Is has been shown to aid in decreasing depression and restoring stability to patients’ moods.
How does SPRAVATO® work?
“Esketamine is the first new medication for depression in many years with a totally different mechanism of action,” says Dr. Vaishnavi, MindPath’s neuropsychiatric expert. “It can act quickly, potentially in days rather than weeks or months, and it may work for patients when previous medications have not.”
Various trials have shown SPRAVATO® to be quite effective. After 16 weeks of therapy, those patients who stayed on SPRAVATO® did better than those who stopped therapy and showed a greater reduction of depression symptoms than those who received only an oral antidepressant.
SPRAVATO® is only available at certified SPRAVATO® treatment centers under the supervision of a healthcare provider.
For more information, including potential side effects and other risks and benefits, please visit the SPRAVATO® website >
How can I get started with SPRAVATO®?
Contact MindPath Care Centers at 877-876-3783 to schedule a consultation to find out if you are a good candidate for SPRAVATO® treatment for depression.
Many major commercial and Medicare plans now cover SPRAVATO® treatment for depression. MindPath Care Centers now accepts Medicare, BCBS, Cigna, Aetna, and Tricare for SPRAVATO® treatment. As with other medical treatments, contact your specific insurance provider to confirm whether SPRAVATO® is covered for you.
Director – Sandeep Vaishnavi, MD, PhD
- MD in Psychiatry from the University of Alabama
- Residency in Psychiatry at Duke University
- Residency in Clinical Psychopharmacology at Duke University and GlaxoSmithKline
- Fellowship in Behavioral Neurology and Neuropsychiatry at Johns Hopkins University School of Medicine
- Double board-certified – Behavioral Neurology & Neuropsychiatry and General Psychiatry
-
Psychiatrist
Charlotte, NC
I offer medication management
- Adjustment Concerns
- Alcohol Use
- Anxiety / Stress
- Bipolar I & II
- Depression
- LGBTQ+ Care
- OCD
- Post-Partum / Pregnancy Depression
- PTSD/Trauma
In-network with:
- BCBS
- Cigna
- Tricare
- Magellan
- Medcost
- Medicare
- UBH
-
Psychiatrist
Raleigh, NC | Telehealth
I offer medication management and telehealth
- ADD/ADHD
- Adjustment Concerns
- Alcohol Use
- Anxiety / Stress
- Bipolar I & II
- Depression
- Eating Disorder
- OCD
- Post-Partum / Pregnancy Depression
- PTSD/Trauma
Telehealth
In-network with:
- Aetna
- BCBS
- Tricare
- Medicare
- UBH
- Humana
- Worker’s Comp
- Gateway
- Alignment
-
Psychiatrist
Durham, NC | Telehealth
I offer medication management and telehealth
- Post-Partum / Pregnancy Depression
- Transcranial Magnetic Stimulation (TMS)
TMS
In-network with:
- Aetna
- BCBS
- Cigna
- Tricare
- Magellan
- Medcost
- UBH
- Alignment
Telehealth
TMS
MindPath Care Centers
1130 Situs Court, Suite 109
Raleigh, NC 27606
MindPath Care Centers
4220 Apex Hwy, Ste 200
Durham, NC 27713
MindPath Care Centers
6060 Piedmont Row Dr S, Ste 500
Charlotte, NC 28287